The glycosylated hemoglobin test evaluates your patient’s response to diabetes therapy. The test measures the degree to which glucose attaches to hemoglobin (a process called glycosylation). Glycosylation occurs continually during the 120-day life of a red blood cell (RBC). The higher the blood glucose level, the greater the attachment. Once glucose attaches to hemoglobin, the process is nearly irreversible, which makes the glycosylated hemoglobin test an accurate reflection of your patient’s average blood glucose level during the 4 to 8 weeks before the test.The test values are given as a percentage of the total hemoglobin within an RBC. Three heĀmoglobins can be measured as Ala, Alb and Alc. The hemoglobin most commonly measured is Alc because it’s normally present in the largest quantity (3% to 6% of total hemoglobin). Ala is typically 1.6%, Alb is 0.8%. The closer to normal the patient can maintain her blood glucose level over an extended period, the closer to normal her glycosylated hemoglobin will be. Nursing considerationsIf your patient uses insulin, she should have a glycosylated hemoglobin test every 3 months. For patients who don’t use insulin, the frequency of the test depends on their response to therapy, which is determined by fasting blood glucose levels. |